Oct 10 (Reuters) - Gentium SpA :
* Receives second list of outstanding issues from the ema's chmp for
defibrotide maa
* Says the second list of outstanding issues has reset the ema's approval
timetable back to day 180
* Says plans to submit its response to the loois within 60 days, in line with
the new regulatory timetable
* Recommendation on approval of defibrotide is now expected in early Q1 2013,
based on the ema review process timeline
* Source text* Further company coverage
((Bangalore Newsroom; +1 646 223 8780))
